Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




World's First Open-Source Real-Time PCR Thermocycler Launched

By LabMedica International staff writers
Posted on 16 Nov 2014
Priced at a tenth the cost of traditional cyclers, the low-cost qPCR thermocycler will especially benefit lesser-funded laboratories and can facilitate diagnostics in developing countries.

Chai Biotechnologies (Santa Clara, CA, USA), a biotech startup focused on making core molecular biological technologies more accessible while developing powerful tools for synthetic biologists, now offers Open qPCR—the world's first open-source real-time PCR thermocycler. More...
The new relative quantitative PCR (qPCR) machine has now been launched via a KickStarter crowdfunding campaign.

As with real-time PCR used in diagnostic and research applications, Open qPCR is capable of genotyping, pathogen presence/absence detection, and relative DNA quantification. With its current 16-well sample capacity (100 µL or 200 µL tubes), it is primarily focused on diagnostics related applications.

The instrument is currently available for USD 1,499 as part of the campaign, and is expected to ship in March 2015. "With Real-Time PCR thermocyclers typically costing USD 20,000 and up, this technology was simply unaffordable to lesser funded university labs, institutes in developing countries dealing with emerging epidemics, and the growing DIYbio [do-it-yourself biology] maker-movement," said Josh Perfetto, founder and chief executive of Chai, "With Open qPCR, we've lowered the cost of the Real-Time PCR reaction by an order of magnitude." CEO Perfetto was also a co-creator of the earlier OpenPCR project, which made the world's first open-source endpoint PCR thermocycler available in 2011.

Features of Open qPCR include: Visual, web-based interface for protocol editing, plate layout, and results interpretation; Integrated touch screen supports field use; Ethernet, Wi-Fi, and USB connectivity; Open API supports automation applications; Low power mode for isothermal amplification applications; Complete hardware design and software, to be released as open source when machine ships.

The KickStarter campaign runs until December 4, 2014. The campaign is also raising funds to donate instruments to Ebola clinics in western Africa.

Related Links:

Chai Biotechnologies
Open qPCR 



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.